Literature DB >> 20572260

A method for obtaining randomized block designs in preclinical studies with multiple quantitative blocking variables.

Stephen J Iturria1.   

Abstract

A method is proposed for block randomization of treatments to experimental units that can accommodate both multiple quantitative blocking variables and unbalanced designs. Hierarchical clustering in conjunction with leaf-order optimization is used to block experimental units in multivariate space. The method is illustrated in the context of a diabetic mouse assay. A simulation study is presented to explore the utility of the proposed randomization method relative to that of a completely randomized approach, both in the presence and absence of covariate adjustment. An example R function is provided to illustrate the implementation of the method.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20572260     DOI: 10.1002/pst.445

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  5 in total

1.  Protective effect of calpain inhibitors against manganese-induced toxicity in rats.

Authors:  I S Ivleva; A P Ivlev; N S Pestereva; T V Tyutyunnik; M N Karpenko
Journal:  Metab Brain Dis       Date:  2022-01-28       Impact factor: 3.584

2.  Changes in activity of µ- and m-calpains and signs of neuroinflammation in the hippocampus and striatum of rats after single intraperitoneal injection of subseptic dose of endotoxin.

Authors:  Viktoriya Maystrenko; Irina Ivleva; Darya Krytskaya; Alexander Zubov; Andrey Ivlev; Marina Karpenko
Journal:  Metab Brain Dis       Date:  2021-05-20       Impact factor: 3.584

3.  Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats.

Authors:  Marisa Möller; Jaco Fourie; Brian H Harvey
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

4.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

5.  The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis.

Authors:  Christian S Thudium; Anne C Bay-Jensen; Suntara Cahya; Ernst R Dow; Morten A Karsdal; Alisa E Koch; Wenling Zhang; Robert J Benschop
Journal:  Arthritis Res Ther       Date:  2020-10-12       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.